#adc Tech News.
1 story in the last 7 days
The latest adc news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks adc across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
HealthFinancial Postabout 2 hours ago
Zymeworks ZW191 Shows 78.6% Response in Ovarian CancerZymeworks presented Phase 1 data for ZW191 at ESMO Gynaecological Cancers Congress 2026. The ADC showed a 78.6% confirmed objective response rate in FRα-positive platinum-resistant ovarian cancer patients and 47.4% in FRα-negative patients. Median progression-free survival was 7.6 months across ovarian and endometrial cancer cohorts.
Summaries by ByteBrief